Lukas Aufinger

Lukas Aufinger

Auto-generated profile, based on publicly available information

Lukas Aufinger

Bruker Dynamic Biosensors, Bruker Daltonics GmbH & Co. KG, Perchtinger Str. 8/10, Munich, Germany, 81379

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
LALukas Aufinger
Lukas Aufinger
FSFriedrich Simmel
Friedrich Simmel

18 December 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FKFlorian Katzmeier
Florian Katzmeier
LALukas Aufinger
Lukas Aufinger
ADAurore Dupin
Aurore Dupin
JQJorge Quintero
Jorge Quintero
MLMatthias Lenz
Matthias Lenz
MHMichael Heymann
Michael Heymann
Point-of-care testing (POCT) in low-resource settings requires tools that can operate independently of typical laboratory infrastructure. Due to its favorable signal-to-background ratio, a wide variety of biomedical tests utilize fluorescence as a readout. However, fluorescence techniques often require expensive or complex instrumentation and can be difficult to adapt for POCT. To address this issue, we developed a pocket-sized fluorescence detector costing less than $15 that is easy to manufacture and can operate in low-resource settings. It is built from standard electronic components, including an LED and a light dependent resistor, filter foils and 3D printed parts, and reliably reaches a lower limit of detection (LOD) of ≈ 6.8 nM fluorescein, which is sufficient to follow typical biochemical reactions used in POCT applications. All assays are conducted on filter paper, which allows for a flat detector architecture to improve signal collection. We validate the device by quantifying in vitro RNA transcription and also demonstrate sequence-specific detection of target RNAs with an LOD of 3.7 nM using a Cas13a-based fluorescence assay. Cas13a is an RNA-guided, RNA-targeting CRISPR effector with promiscuous RNase activity upon recognition of its RNA target. Cas13a sensing is highly specific and adaptable and in combination with our detector represents a promising approach for nucleic acid POCT. Furthermore, our open-source device may be used in educational settings, through providing low cost instrumentation for quantitative assays or as a platform to integrate hardware, software and biochemistry concepts in the future.

8 April 2022 in Science Advances
Verified
Journal Article
Open access
ADAurore Dupin
Aurore Dupin
LALukas Aufinger
Lukas Aufinger
ISIgor Styazhkin
Igor Styazhkin
FRFlorian Rothfischer
Florian Rothfischer
BKBenedikt K. Benedikt K. Kaufmann
Benedikt K. Benedikt K. Kaufmann
FSFriedrich Simmel
Friedrich Simmel
Biomaterials composed of synthetic cells have the potential to adapt and differentiate guided by physicochemical environmental cues. Inspired by biological systems in development, which extract positional information (PI) from morphogen gradients in the presence of uncertainties, we here investigate how well synthetic cells can determine their position within a multicellular structure. To calculate PI, we created and analyzed a large number of synthetic cellular assemblies composed of emulsion droplets connected via lipid bilayer membranes. These droplets contained cell-free feedback gene circuits that responded to gradients of a genetic inducer acting as a morphogen. PI is found to be limited by gene expression noise and affected by the temporal evolution of the morphogen gradient and the cell-free expression system itself. The generation of PI can be rationalized by computational modeling of the system. We scale our approach using three-dimensional printing and demonstrate morphogen-based differentiation in larger tissue-like assemblies.

23 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LALukas Aufinger
Lukas Aufinger
JBJohann Brenner
Johann Brenner
FSFriedrich Simmel
Friedrich Simmel
Complex dynamics such as period doubling and chaos occur in a wide variety of non-linear dynamical systems. In the context of biological circadian clocks, such phenomena have been previously found in computational models, but their experimental study in biological systems has been challenging. Here, we present experimental evidence of period doubling in a forced cell-free genetic oscillator operated in a microfluidic reactor, where the system is periodically perturbed by modulating the concentration of one of the oscillator components. When the external driving matches the intrinsic period, we experimentally find period doubling and quadrupling in the oscillator dynamics. Our results closely match the predictions of a theoretical model, which also suggests conditions under which our system would display chaotic dynamics. We show that detuning of the external and intrinsic period leads to more stable entrainment, suggesting a simple design principle for synchronized synthetic and natural genetic clocks.

12 July 2019 in bioRxiv
Verified
Preprint
Open access
FKFlorian Katzmeier
Florian Katzmeier
LALukas Aufinger
Lukas Aufinger
ADAurore Dupin
Aurore Dupin
JQJorge Quinteiro
Jorge Quinteiro
MLMatthias Lenz
Matthias Lenz
MHMichael Heymann
Michael Heymann
Point-of-care testing (POCT) in low-resource settings requires tools that can operate independent of typical laboratory infrastructure. Due to its favorable signal-to-background ratio, a wide variety of biomedical tests utilize fluorescence as a readout. However, fluorescence techniques often require expensive or complex instrumentation and can be difficult to adapt for POCT. To address this issue, we developed a pocket-sized fluorescence detector costing less than $15 that is easy to manufacture and can operate in low-resource settings. It is built from standard electronic components, including an LED and a light dependent resistor, filter foils and 3D printed parts, and reliably detected less than 10 nM fluorescein concentrations (with a lower limit of detection of ≈6.8 nM), which is sufficient to follow typical biochemical reactions used in POCT applications. All assays are conducted on filter paper, which allows for a flat detector architecture to improve signal collection. We validate the device by quantifying in vitro RNA transcription and also demonstrate sequence-specific detection of target RNAs in the nanomolar range using a Cas13a-based fluorescence assay. Cas13a is a RNA-guided, RNA-targeting CRISPR effector with promiscuous RNase activity upon recognition of its RNA target. Cas13a sensing is highly specific and adaptable and in combination with our detector represents a promising approach for nucleic acid POCT. Furthermore, our open-source device architecture could be a valuable educational tool that integrates hardware, software and biochemistry concepts.